Tuberculosis News and Research

Latest Tuberculosis News and Research

MOOCs courses offered by JHUSON concentrate on Dementia and TB

An aging population and an old health scourge are the driving forces behind two massive open online courses (MOOCs) being offered this fall by the Johns Hopkins University School of Nursing (JHUSON).

14 Aug 2013

Complex and messy ethical, social and cultural issues often left on table

Resolving complex ethical, social and cultural issues in the early stage of a global health research project or clinical trial can improve the impact and quality of that research, a new report says.

12 Aug 2013

Study reveals genetic mutations linked to Parkinson's may play a role in death of brain cells

Researchers have discovered how genetic mutations linked to Parkinson's disease might play a key role in the death of brain cells, potentially paving the way for the development of more effective drug treatments.

12 Aug 2013

Researchers identify biomarkers of TB that may help in new treatments

Researchers at the University of Southampton have identified new markers of tuberculosis (TB) that may help in the development of new diagnostic tests and treatments.

12 Aug 2013

University of Surrey scientists move one step closer to find successful treatment for TB

Scientists at the University of Surrey have undertaken research into tuberculosis which could result in quicker treatment for sufferers and potentially reduce the problem of drug-resistance.

9 Aug 2013

China CDC, Aeras sign MOU to advance research, development of new TB vaccines

With the global tuberculosis epidemic becoming more deadly, costly, and difficult to treat, Chinese Center for Disease Control and Prevention and Aeras today signed a memorandum of understanding to advance research and development of new tuberculosis vaccines. An improved TB vaccine offers the best hope for eliminating this airborne infectious disease that kills 1.4 million people worldwide each year.

3 Aug 2013

BMC, BUSM and JIPMER to jointly research on tuberculosis

Boston Medical Center and Boston University School of Medicine are partnering with the Jawaharlal Institute of Postgraduate Medical Education and Research to study tuberculosis. This research is supported by a five-year, $2.5 million grant from the Indo-U.S. Vaccine Action Program.

2 Aug 2013

MAPS method could speed development of new vaccines for serious pathogens

A new method of vaccine design, called the Multiple Antigen Presentation System, may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

1 Aug 2013

Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

Cancer immunotherapy aims to recruit a patient’s immune system to recognize cancer as foreign and dangerous and to remove it from the body, as it would an infection.

1 Aug 2013

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

Genotype 1 is, worldwide, the most prevalent genotype of the hepatitis C virus. It accounts for around seventy percent of all hepatitis C infections.

30 Jul 2013

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

The slightest variation in a sequence of DNA can have profound effects. Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body.

29 Jul 2013

FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB

The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.

26 Jul 2013

Researcher identify genetic mutation in Africans with HIV that puts them at higher risk for tuberculosis

A researcher from the Perelman School of Medicine at the University of Pennsylvania and colleagues have identified the genetic mutation in Africans with HIV that puts them at a much higher risk for tuberculosis (TB) infections.

25 Jul 2013

Cepheid, American Lung Association partner to promote TB awareness in U.S.

Cepheid and the American Lung Association today announced a partnership to promote tuberculosis-related awareness in the U.S. and the need for improved TB diagnostics.

23 Jul 2013

Serum Institute of India secures license to patents, technologies related to tuberculosis vaccine

Hopes are high for a new and improved tuberculosis vaccine: Serum Institute of India is planning on taking a promising vaccine - originally developed in Germany - and introducing it into the clinical setting.

23 Jul 2013

Understanding cancer at source could improve disease prevention

A new disease is affecting developing countries, deadlier than malaria, AIDS and tuberculosis combined. With changes in lifestyles, cancer is spreading in southern countries.

23 Jul 2013

Metagenomics technique used to recover TB genomes from 215-year old mummy

Researchers at the University of Warwick have recovered tuberculosis (TB) genomes from the lung tissue of a 215-year old mummy using a technique known as metagenomics.

20 Jul 2013

State highlights: D.C. health care providers continue wait for payments; Ga. plans Medicaid managed care for kids; Hospital chain seeks insurer license in Calif.

A selection of health policy stories from Virginia, the District of Columbia, California, Wisconsin, Georgia, South Carolina, Pennsylvania and Washington.

19 Jul 2013

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.

19 Jul 2013

First Edition: July 18, 2013

Today's headlines include reports about the House vote to delay the health law's mandates as well as advance coverage of President Barack Obama's Thursday speech in which he touts the overhaul's benefits.

18 Jul 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

MOOCs courses offered by JHUSON concentrate on Dementia and TB

Complex and messy ethical, social and cultural issues often left on table

Study reveals genetic mutations linked to Parkinson's may play a role in death of brain cells

Researchers identify biomarkers of TB that may help in new treatments

University of Surrey scientists move one step closer to find successful treatment for TB

China CDC, Aeras sign MOU to advance research, development of new TB vaccines

BMC, BUSM and JIPMER to jointly research on tuberculosis

MAPS method could speed development of new vaccines for serious pathogens

Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

Interferon-free treatment for genotype-1b hepatitis C patients: an interview with Professor Wulf Boecher, Boehringer Ingelheim

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

FDA allows marketing of Xpert MTB/RIF Assay for treatment of TB

Researcher identify genetic mutation in Africans with HIV that puts them at higher risk for tuberculosis

Cepheid, American Lung Association partner to promote TB awareness in U.S.

Serum Institute of India secures license to patents, technologies related to tuberculosis vaccine

Understanding cancer at source could improve disease prevention

Metagenomics technique used to recover TB genomes from 215-year old mummy

State highlights: D.C. health care providers continue wait for payments; Ga. plans Medicaid managed care for kids; Hospital chain seeks insurer license in Calif.

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

First Edition: July 18, 2013

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in